Mental Health Solutions

AHI to target active mental health industry

Finfeed Archived May 31, 2021

Advanced Human Imaging Limited (ASX: AHI) has signed a binding term sheet with INTER-PSY B.V (Inter-Psy), a Netherlands based mental health and addition care company that has developed Health i Check, a preventative health screening app for the Dutch and European markets.

$15M grant for psychedelics studies as calls to combat mental health intensify

Finfeed Archived Mar 18, 2021

Australia’s federal government will grant $15M to clinical studies that explore the use of psychedelic drugs like magic mushrooms and ecstasy, to treat Australians with debilitating mental illnesses.

Creso Pharma set to be the first ASX listed entrant in new market

Finfeed Archived Mar 15, 2021

Creso Pharma Limited (ASX:CPH, FRA:1X8) has signed an agreement to acquire Halucenex Life Sciences Inc. (Halucenex), an established psychedelics company focused on developing treatments for Treatment Resistant Depression in individuals suffering from PTSD, and other mental health illnesses.

CPH to be the First ASX Stock to Acquire 100% of a Psychedelics Company

Next Investors Mar 15, 2021

Creso Pharma (ASX: CPH) will be the first ASX listed stock to acquire 100% of a psychedelics company. CPH is set to acquire Canada based Halucenex Life Sciences Inc., an established psychedelics company developing treatments for a range of mental illnesses.